Targeting FGFR inhibition in cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2021.102170
Abstract: Cholangiocarcinomas (CCAs) are rare but aggressive tumours of the bile ducts, which are often diagnosed at an advanced stage and have poor outcomes on systemic therapy. Somatic alterations with therapeutic implications have been identified in… read more here.
Keywords: targeting fgfr; inhibition; inhibition cholangiocarcinoma; fgfr inhibitors ... See more keywords
FGFR2 Inhibition in Cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Annual review of medicine"
DOI: 10.1146/annurev-med-042921-024707
Abstract: Biliary tract cancer (BTC) is the second most common primary liver cancer after hepatocellular carcinoma and accounts for 2% of cancer-related deaths. BTCs are classified according to their anatomical origin into intrahepatic (iCCA), perihilar, or… read more here.
Keywords: inhibition cholangiocarcinoma; icca; fgfr2 inhibition; medicine ... See more keywords